Cargando…

Effects of enhancer of zeste homolog 2 and mucin 1 expressions on treatment response in breast cancer

OBJECTIVE: Breast cancer is the most common malignancy in women. In the treatment of these patients, pathological complete response is defined as the absence of invasive cancer in breast or lymph node tissue after the completion of neoadjuvant chemotherapy. In this study, we aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yetişir, Abdullah Evren, Paydaş, Semra, Büyükşimşek, Mahmut, Oğul, Ali, Yaprak, Özge, Zorludemir, Suzan, Ergin, Melek, Kolsuz, İrem, Kidi, Mehmet Mutlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Médica Brasileira 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937598/ https://www.ncbi.nlm.nih.gov/pubmed/36820722 http://dx.doi.org/10.1590/1806-9282.20221123

Ejemplares similares

Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
por: Büyükşimşek, Mahmut, et al.
Publicado: (2020)

Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report
por: Büyükşimşek, Mahmut, et al.
Publicado: (2018)

Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma
por: Büyükşimşek, Mahmut, et al.
Publicado: (2019)

Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study
por: Mirili, Cem, et al.
Publicado: (2019)

Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers
por: Paydaş, Saime, et al.
Publicado: (2013)

Sweet Syndrome in a Patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Curious Lymphocyte/Neutrophil Fluctuations
por: Usul Afşar, Çiğdem, et al.
Publicado: (2013)

Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma
por: JIA, NAN, et al.
Publicado: (2014)

Extramedullary Myeloid Tumor Involving the Pancreas: A Case Report and Review of the Literature
por: Paydaş, Semra, et al.
Publicado: (2014)

Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
por: Nakagawa, Makoto, et al.
Publicado: (2018)

Results of Liquid Biopsy Studies by Next Generation Sequencing in Patients with Advanced Stage Non-small Cell Lung Cancer: Single Center Experience from Turkey
por: Buyuksimsek, M, et al.
Publicado: (2019)

Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion
por: ZHOU, MIN, et al.
Publicado: (2014)

Targeting enhancer of zeste homolog 2 protects against acute kidney injury
por: Zhou, X., et al.
Publicado: (2018)

Impact of Enhancer of Zeste Homolog 2 on T Helper Cell-Mediated Allergic Rhinitis
por: Hou, Tsung-Yun, et al.
Publicado: (2017)

Abdominal actinomycosis with multiple myeloma: A case report
por: ERCOLAK, VEHBI, et al.
Publicado: (2014)

Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman A., et al.
Publicado: (2012)

Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis
por: Chen, Shuling, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
por: Lv, Yang-Fan, et al.
Publicado: (2015)

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
por: Sun, Si, et al.
Publicado: (2018)

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)

Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells
por: Ma, Huarui, et al.
Publicado: (2019)

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
por: Kang, Yuanyuan, et al.
Publicado: (2021)

Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia
por: Hamed, Nahla A. M., et al.
Publicado: (2023)

Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
por: Ciarapica, Roberta, et al.
Publicado: (2011)

Correction: Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman A., et al.
Publicado: (2012)

Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
por: Dahlby, Tina, et al.
Publicado: (2020)

Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningioma
por: Zeng, Jing, et al.
Publicado: (2022)

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
por: Wagener, Nina, et al.
Publicado: (2010)

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
por: Hayashi, Satoshi, et al.
Publicado: (2011)

Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4
por: Lu, H, et al.
Publicado: (2013)

Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes
por: WANG, HUALI, et al.
Publicado: (2015)

Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis
por: Cheng, Tianci, et al.
Publicado: (2018)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2017)

Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis
por: Huang, Xinyue, et al.
Publicado: (2020)

Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer
por: Shi, Bin, et al.
Publicado: (2019)

Novel Natural Inhibitors Targeting Enhancer of Zeste Homolog 2: A Comprehensive Structural Biology Research
por: Li, Weihang, et al.
Publicado: (2021)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2021)

Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase
por: Ott, Martina, et al.
Publicado: (2012)

119 Enhancer of Zeste Homolog 2: A Pivotal Role in Pulmonary Artery Smooth Muscle Cell Proliferation
por: Aljubran, Salman, et al.
Publicado: (2012)

Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer
por: Ishikawa, S, et al.
Publicado: (2014)

Downregulation of Enhancer of Zeste Homolog 2 (EZH2) is essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer Cells
por: Yao, Yizhou, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_msnoa9b800uue28abfem0hj5ke